P419: IDENTIFICATION OF NOVEL THERAPEUTIC OPTIONS FOR VENETOCLAX‐RESISTANT AML CELLS THROUGH DRUG REPURPOSING
Ladungova, A., Busa, D., Lodhi, Y., Hyl, J., Culen, M., Smida, M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article